ARXS Arxis, Inc.
Nasdaq · SEC CIK 2093536 · EDGAR
- Bought, last 12 months
- $5.64M 7 purchases by 7 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 11 since 2026-04-20, latest 2026-08-21 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Roth Jason Aaron | See Remarks | $1.68M | — |
| Perhamus Kevin Scott | See Remarks, Dir | $1.50M | — |
| Badakhsh Azad Sid | See Remarks | $1.01M | — |
| Oetgen Stephen Duane | Dir | $700.0K | — |
| Sealfon Ross Bradley | See Remarks | $350.0K | — |
| ALLEN PATRICK E | Dir | $280.0K | — |
| Jankowski Ryan Anthony | CAO | $125.0K | — |
| Arcline Double Eagle Master Fund-A LP | Dir, 10% | — | — |
| Allen Jennifer H. | See Remarks | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-21 16:05 | 2026-08-19 | ARXS | Roth Jason Aaron | See Remarks | A - Grant | $0.00 | +34.1K | 429.6K | +9% | $0 | |
| 2026-07-01 19:29 | 2026-06-29 | ARXS | Jankowski Ryan Anthony | CAO | A - Grant | $0.00 | +8,517 | 59.8K | +17% | $0 | |
| 2026-04-20 21:15 | 2026-04-16 | ARXS | Jankowski Ryan Anthony | CAO | A - Grant | — | +46.9K | 46.9K | New | — | |
| 2026-04-20 21:15 | 2026-04-17 | ARXS | Jankowski Ryan Anthony | CAO | P - Purchase | $28.00 | +4,464 | 51.3K | +10% | +$125.0K | |
| 2026-04-20 21:14 | 2026-04-16 | ARXS | Allen Jennifer H. | See Remarks | A - Grant | — | +53.7K | 53.7K | New | — | |
| 2026-04-20 21:12 | 2026-04-16 | ARXS | Badakhsh Azad Sid | See Remarks | A - Grant | — | +367.9K | 367.9K | New | — | |
| 2026-04-20 21:12 | 2026-04-17 | ARXS | Badakhsh Azad Sid | See Remarks | P - Purchase | $28.00 | +36.0K | 403.9K | +10% | +$1.01M | |
| 2026-04-20 21:08 | 2026-04-16 | ARXS | Sealfon Ross Bradley | See Remarks | A - Grant | — | +1.09M | 1.09M | New | — | |
| 2026-04-20 21:08 | 2026-04-17 | ARXS | Sealfon Ross Bradley | See Remarks | P - Purchase | $28.00 | +12.5K | 1.10M | +1% | +$350.0K | |
| 2026-04-20 21:07 | 2026-04-17 | ARXS | Oetgen Stephen Duane | Dir | A - Grant | $0.00 | +5,357 | 5,357 | New | $0 | |
| 2026-04-20 21:07 | 2026-04-17 | ARXS | Oetgen Stephen Duane | Dir | P - Purchase | $28.00 | +25.0K | 30.4K | +467% | +$700.0K | |
| 2026-04-20 21:04 | 2026-04-17 | ARXS | ALLEN PATRICK E | Dir | A - Grant | $0.00 | +5,357 | 5,357 | New | $0 | |
| 2026-04-20 21:04 | 2026-04-17 | ARXS | ALLEN PATRICK E | Dir | P - Purchase | $28.00 | +10.0K | 15.4K | +187% | +$280.0K | |
| 2026-04-20 21:04 | 2026-04-16 | ARXS | Perhamus Kevin Scott | See Remarks, Dir | A - Grant | — | +3.52M | 3.52M | New | — | |
| 2026-04-20 21:04 | 2026-04-17 | ARXS | Perhamus Kevin Scott | See Remarks, Dir | P - Purchase | $28.00 | +53.6K | 3.57M | +2% | +$1.50M | |
| 2026-04-20 20:59 | 2026-04-16 | ARXS | Roth Jason Aaron | See Remarks | A - Grant | — | +335.5K | 335.5K | New | — | |
| 2026-04-20 20:59 | 2026-04-17 | ARXS | Roth Jason Aaron | See Remarks | P - Purchase | $28.00 | +60.0K | 395.5K | +18% | +$1.68M | |
| DI | 2026-04-20 20:59 | 2026-04-16 | ARXS | Arcline Double Eagle Master Fund-A LP | Dir, 10% | A - Grant | $0.00 | +1 | 1 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations